SCHEMBL3141259

SCHEMBL3141259

Nc1ccc(OC(=O)c2ccc(-c3ccc(C(=O)Oc4ccc(Cl)cc4Cl)cc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.47
F2 P00734 2/20 0.47
PRSS1 P07477 2/20 0.47
PRSS2 P07478 2/20 0.47
PRSS3 P35030 2/20 0.47
PKM P14618 1/20 0.47
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
RAB9A P51151 2/20 0.45
CYP3A4 P08684 1/20 0.45
MAPT P10636 2/20 0.45
NR1H4 Q96RI1 1/20 0.43
MEN1 O00255 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MRGPRX4 Q96LA9 1/20 0.42
HTT P42858 1/20 0.42
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3143586 0.87 MRGPRX4 (0.51) KMT2ANPC1ALDH1A1CYP1A2CYP2C9
SCHEMBL3144272 0.86 KMT2A (0.56) KMT2AF2PRSS1PRSS2PRSS3
SCHEMBL3149467 0.84 KMT2A (0.49) KMT2AF2PRSS1PRSS2PRSS3
SCHEMBL11648001 0.81 KMT2A (0.61) KMT2AF2PRSS1PRSS2PRSS3
SCHEMBL3143505 0.81 PRSS1 (0.65) KMT2AF2PRSS1PRSS2PRSS3
SCHEMBL22310501 0.81 PRSS1 (0.65) KMT2AF2PRSS1PRSS2PRSS3
SCHEMBL10021501 0.81 PRSS1 (0.65) KMT2AF2PRSS1PRSS2PRSS3
SCHEMBL17826638 0.78 SENP1 (0.46) KMT2APRSS1PRSS2PRSS3PKM
SCHEMBL17301243 0.78 MAPT (0.50) KMT2AMAPTMEN1
SCHEMBL3149936 0.78 KMT2A (0.63) KMT2AF2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041860-A1 POLYIMIDE, DIAMINE COMPOUND AND METHOD FOR PRODUCING THE SAME UBE INDUSTRIES, LTD. (JP) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041860-A1 POLYIMIDE, DIAMINE COMPOUND AND METHOD FOR PRODUCING THE SAME DDC, AOC1, DDT KMT2A 334/4885F2 574/4885PRSS1 4140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.